Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ashwin Reddy

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Ophthalmic Genetics|May 11, 2010
Cerebrotendinous xanthomatosis (CTX): an association of pulverulent cataracts and pseudo-dominant developmental delay in a family with a splice site mutation in CYP27A1--a case reportRabia Bourkiza, Sarah Joyce, Himanshu Patel, et al.
Ophthalmic Genetics|November 1, 2022
Ruthenium plaque radiotherapy in the current era of retinoblastoma treatmentGuy S Negretti, Hibba Quhill, Catriona Duncan, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|October 22, 2015
Electroretinogram assessment of children with sensorineural hearing loss: implications for screeningStephanie K West, Maya Hindocha, Chris R Hogg, et al.
American Journal of Ophthalmology|May 15, 2017
Long-term Visual Acuity, Strabismus, and Nystagmus Outcomes Following Multimodality Treatment in Group D Retinoblastoma EyesIdo D Fabian, Zishan Naeem, Andrew W Stacey, et al.
The British Journal of Ophthalmology|September 17, 2013
Visual outcomes following intraophthalmic artery melphalan for patients with refractory retinoblastoma and age appropriate visionMaria Tsimpida, Dorothy A Thompson, Alki Liasis, et al.
Ophthalmology. Retina|August 25, 2020
Prognostic Information for Known Genetic Carriers of RB1 Pathogenic Variants (Germline and Mosaic)M Ashwin Reddy, Mussa Butt, Anne-Marie Hinds, et al.
Ophthalmic Genetics|May 18, 2021
<i>MYCN</i> amplification levels in primary retinoblastoma tumors analyzed by Multiple Ligation-dependent Probe AmplificationElizabeth A Price, Roopal Patel, Irene Scheimberg, et al.
Ocular Oncology and Pathology|January 25, 2019
The Incidence of Binocular Visual Impairment and Blindness in Children with Bilateral RetinoblastomaAndrew W Stacey, Bronagh Clarke, Christos Moraitis, et al.
European Journal of Ophthalmology|April 29, 2022
Changing trends in pseudoretinoblastoma diagnoses: A 10 year review from the United KingdomVinay Badhwar, Damien Cm Yeo, Samruddhi Joshi, et al.
Eye (London, England)|February 2, 2022
Systemic adjuvant chemotherapy for advanced malignant ocular medulloepitheliomaIbrahim H N Sheriff, Esin K Karaa, Tanzina Chowdhury, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Ophthalmic Genetics|May 11, 2010
Cerebrotendinous xanthomatosis (CTX): an association of pulverulent cataracts and pseudo-dominant developmental delay in a family with a splice site mutation in CYP27A1--a case reportRabia Bourkiza, Sarah Joyce, Himanshu Patel, et al.
Ophthalmic Genetics|November 1, 2022
Ruthenium plaque radiotherapy in the current era of retinoblastoma treatmentGuy S Negretti, Hibba Quhill, Catriona Duncan, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|October 22, 2015
Electroretinogram assessment of children with sensorineural hearing loss: implications for screeningStephanie K West, Maya Hindocha, Chris R Hogg, et al.
American Journal of Ophthalmology|May 15, 2017
Long-term Visual Acuity, Strabismus, and Nystagmus Outcomes Following Multimodality Treatment in Group D Retinoblastoma EyesIdo D Fabian, Zishan Naeem, Andrew W Stacey, et al.
The British Journal of Ophthalmology|September 17, 2013
Visual outcomes following intraophthalmic artery melphalan for patients with refractory retinoblastoma and age appropriate visionMaria Tsimpida, Dorothy A Thompson, Alki Liasis, et al.
Ophthalmology. Retina|August 25, 2020
Prognostic Information for Known Genetic Carriers of RB1 Pathogenic Variants (Germline and Mosaic)M Ashwin Reddy, Mussa Butt, Anne-Marie Hinds, et al.
Ophthalmic Genetics|May 18, 2021
<i>MYCN</i> amplification levels in primary retinoblastoma tumors analyzed by Multiple Ligation-dependent Probe AmplificationElizabeth A Price, Roopal Patel, Irene Scheimberg, et al.
Ocular Oncology and Pathology|January 25, 2019
The Incidence of Binocular Visual Impairment and Blindness in Children with Bilateral RetinoblastomaAndrew W Stacey, Bronagh Clarke, Christos Moraitis, et al.
European Journal of Ophthalmology|April 29, 2022
Changing trends in pseudoretinoblastoma diagnoses: A 10 year review from the United KingdomVinay Badhwar, Damien Cm Yeo, Samruddhi Joshi, et al.
Eye (London, England)|February 2, 2022
Systemic adjuvant chemotherapy for advanced malignant ocular medulloepitheliomaIbrahim H N Sheriff, Esin K Karaa, Tanzina Chowdhury, et al.
Pageof 8